As the global population ages, maintaining health and wellness in older adults presents increasingly urgent challenges. Among the most significant health threats facing this demographic are chronic inflammation, cognitive decline, and rising cardiometabolic risk factors. These issues, if left unaddressed, may severely impact the quality of life in older adults.

In this context, natural interventions like pomegranate extract offer promising solutions. Pomanox®, a premium pomegranate extract by Spanish ingredient manufacturer Euromed S.A., has shown potential in supporting healthy ageing, reducing inflammatory markers, and improving cognitive function—key areas of concern for the ageing population. This webinar will review the latest clinical evidence, offering insights on how pomegranate extract can serve as an effective ingredient for product developers seeking to address the needs of older consumers.

Join Dr. Grace Farhat, Senior Lecturer in Nutrition and Dietetics at Manchester Metropolitan University, as she presents the outcomes of a recent clinical trial on Pomanox. The study, conducted with healthy adults aged 55-70, investigates its impact on cognitive function, blood pressure, inflammatory markers, and ageing factors.

Learning Objectives of this webinar:

• Nutraceuticals market trends insights for healthy ageing.
• The role of Pomanox in reducing inflammatory markers and its potential for improving cardiometabolic health in older adults.
• How Pomanox supports cognitive function, potentially aiding in the prevention of age-related cognitive decline.
• The potential of Pomanox in promoting longevity, making it a valuable ingredient for formulations targeting the ageing population.